UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~July~~October 1727, ~~2013~~2015

LIFE CARE MEDICAL DEVICES LIMITED

(Exact Name of Registrant as Specified in Charter)

Nevada

000-54632

98-0576696

(State or Other Jurisdiction

of Incorporation)

(Commission
File Number)

(IRS Employer

Identification No.)

880 Third Avenue, Suite 905, New York, NY 10022 (Address of Principal Executive Offices) (Zip Code)

257 Minorca Beach Way, Suite 1606, New Smyrna Beach, FL	32169
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s Telephone Number, Including Area Code: (~~917~~386) ~~860~~410-~~4514~~4239

880 Third Avenue, Suite 905, New York, NY 10022

(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

q¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

q¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

q¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

q¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.01. Entry into a Material Definitive Agreement.

On July 17, 2013, Life Care Medical Devices Limited (the “Company”) entered into a Distributor Agreement with Malesa MD&D, providing Malesa MD&D with exclusive distribution rights for the Company’s Keyhole Cup® Laparoscopic Access Device.

Under the agreement, Malesa MD&D will promote, at its expense, and sell the products within the Kingdom of Saudi Arabia. Additionally, Malesa MD&D must establish a sales network and treat our products as one of its primary lines of medical device products.

The agreement’s initial term runs until July 17, 2014, and will be automatically extended for an additional 12 months subject to Malesa MD&D achieving performance targets for the first year. Additionally, the agreement is subject to extension by mutual agreement of the parties. Either party may terminate the agreement upon 180 days’ written notice. Either party may terminate the agreement immediately for just cause upon the other party’s breach of the agreement.

The foregoing summary of the terms of the agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the agreement, a copy of which will be filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ending September 30, 2013.

Item 8.01.

Other Events.

On ~~July~~October 2216, ~~2013~~2015, Life Care Medical Devices Limited (the “Company”) ~~issued~~became aaware ~~press~~that the Securities and Exchange Commission (the “Commission”) ~~release~~intended ~~announcing~~to ~~its~~issue ~~agreement~~an ~~with~~order ~~Malesa~~to ~~MD&D~~schedule ~~regarding~~a ~~distribution~~public hearing for the purpose of taking evidence to determine whether the registration of the Company’s ~~Keyhole~~common ~~Cup~~stock ~~Laparoscopic~~under ~~Access~~the Securities Exchange Act of 1934, as amended (the “Exchange Act”), should ~~Device~~be suspended or revoked due to a failure to file the required Exchange Act reports in a timely manner. Pursuant to ARule ~~copy~~240(a) of ~~this~~the ~~press~~Rules ~~release~~of isPractice ~~attached~~of asthe ~~Exhibit~~Commission, 99the Company has submitted an offer to the Commission to voluntarily resolve the issue.1 As a result, the Company expects its common stock to be deregistered in the near future pursuant to Section 12(j) of the Exchange Act. The Company has the right to re-register at any time in the future via the filing of a Form 10, assuming it meets that Form's filing requirements. The company intends to file the Form 10 in the near future.

~~Item~~As 9noted on the cover page of this Report, the Company’s address is 257 Minorca Beach Way, Suite 1606, New Smyrna Beach, Florida 32169 and its current telephone number is (386) 410-4239.01 The Company’s Chief Executive Officer is Richard Prati. ~~Financial~~No ~~Statements~~prior ~~and~~periodic ~~Exhibits~~or current report had been filed by the Company to provide this information.

(d) Exhibit No. Description

99.1 Press release dated July 22, 2013.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LIFE CARE MEDICAL DEVICES LIMITED

	LIFE CARE MEDICAL DEVICES LIMITED


Date: October 29, 2015	/s/ Richard Prati
	Name: Richard Prati
	Title: Chief Executive Officer

Date: July 22, 2013

/s/ Glenn Foley

Name: Glenn Foley

Title: Chief Executive Officer

Filing Compare · Life Care Medical Devices Ltd